Mankind Pharma Limited (NSE:MANKIND)
India
· Delayed Price · Currency is INR 2,404.00
-35.50 (-1.46%)
May 9, 2025, 3:29 PM IST
Mankind Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 |
| Net Income | 19,129 | 12,819 | 14,335 | 12,654 | 10,304 | Upgrade
|
| Depreciation & Amortization | 3,895 | 3,208 | 1,616 | 1,154 | 963 | Upgrade
|
| Other Amortization | 87.32 | 51.07 | 49.83 | 35.27 | 27.58 | Upgrade
|
| Loss (Gain) From Sale of Assets | -4.8 | -16.65 | 37.41 | 30.45 | -109.54 | Upgrade
|
| Asset Writedown & Restructuring Costs | 91.63 | 135.6 | -22.37 | 38.88 | 905.83 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1,335 | -374.31 | -1,049 | -451.54 | -350.59 | Upgrade
|
| Loss (Gain) on Equity Investments | -152.14 | -124.24 | -144.48 | -116.77 | -115.35 | Upgrade
|
| Stock-Based Compensation | 231.86 | 0.59 | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 139.13 | 137.89 | 115.43 | 7.54 | 13.55 | Upgrade
|
| Other Operating Activities | -801.61 | 609.71 | 91.25 | -1,049 | 432.4 | Upgrade
|
| Change in Accounts Receivable | -2,899 | -2,053 | -659.53 | 2,002 | -3,088 | Upgrade
|
| Change in Inventory | -550.03 | 2,618 | -5,767 | -2,844 | -781.49 | Upgrade
|
| Change in Accounts Payable | 974.52 | -650.19 | 4,198 | -781.51 | 1,831 | Upgrade
|
| Change in Other Net Operating Assets | 2,679 | 1,753 | -3,633 | 676.93 | 637.62 | Upgrade
|
| Operating Cash Flow | 21,524 | 18,133 | 9,198 | 11,372 | 10,722 | Upgrade
|
| Operating Cash Flow Growth | 18.70% | 97.15% | -19.12% | 6.07% | 78.59% | Upgrade
|
| Capital Expenditures | -3,153 | -7,890 | -4,649 | -3,054 | -2,280 | Upgrade
|
| Sale of Property, Plant & Equipment | 75.07 | 60.48 | 31.46 | 7.43 | 112.42 | Upgrade
|
| Cash Acquisitions | - | -38.27 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -670.03 | -430.49 | -18,807 | -69.05 | - | Upgrade
|
| Investment in Securities | -17,388 | -2,366 | 9,430 | -9,478 | -2,506 | Upgrade
|
| Other Investing Activities | 319.5 | 123.57 | 302.84 | 374.47 | 140.39 | Upgrade
|
| Investing Cash Flow | -20,817 | -10,541 | -13,691 | -12,222 | -4,392 | Upgrade
|
| Short-Term Debt Issued | 3,746 | 10,947 | 12,723 | 1,268 | 138.79 | Upgrade
|
| Long-Term Debt Issued | 260.93 | 38.45 | 58.6 | 4,522 | 610.42 | Upgrade
|
| Total Debt Issued | 4,007 | 10,986 | 12,782 | 5,789 | 749.21 | Upgrade
|
| Short-Term Debt Repaid | -3,398 | -17,642 | -6,454 | -176.98 | -2,111 | Upgrade
|
| Long-Term Debt Repaid | -294.57 | -322.25 | -104.29 | -4,519 | -45.89 | Upgrade
|
| Total Debt Repaid | -3,693 | -17,964 | -6,558 | -4,696 | -2,157 | Upgrade
|
| Net Debt Issued (Repaid) | 314.39 | -6,978 | 6,224 | 1,094 | -1,407 | Upgrade
|
| Common Dividends Paid | - | - | - | - | -3,024 | Upgrade
|
| Other Financing Activities | -261.74 | -419.31 | -177.86 | -1,172 | -837.94 | Upgrade
|
| Financing Cash Flow | 52.66 | -7,397 | 6,046 | -78.11 | -5,270 | Upgrade
|
| Foreign Exchange Rate Adjustments | 11.67 | 23.15 | 4.78 | 3.75 | 36.04 | Upgrade
|
| Net Cash Flow | 771.87 | 217.6 | 1,557 | -924.03 | 1,097 | Upgrade
|
| Free Cash Flow | 18,371 | 10,243 | 4,549 | 8,318 | 8,442 | Upgrade
|
| Free Cash Flow Growth | 79.36% | 125.16% | -45.31% | -1.47% | 178.90% | Upgrade
|
| Free Cash Flow Margin | 17.78% | 11.71% | 5.85% | 13.38% | 14.38% | Upgrade
|
| Free Cash Flow Per Share | 45.79 | 25.57 | 11.36 | 20.77 | 21.07 | Upgrade
|
| Cash Interest Paid | 261.74 | 419.31 | 177.86 | 171 | 219.72 | Upgrade
|
| Cash Income Tax Paid | 4,795 | 3,231 | 4,995 | 4,541 | 3,309 | Upgrade
|
| Levered Free Cash Flow | 12,147 | 7,117 | -16,379 | 5,813 | 7,526 | Upgrade
|
| Unlevered Free Cash Flow | 12,326 | 7,369 | -16,031 | 5,934 | 7,661 | Upgrade
|
| Change in Net Working Capital | 1,514 | -2,503 | 5,693 | 2,072 | 241.11 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.